Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials

Overview of attention for article published in BMC Infectious Diseases, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 11,079 followers.

RT @2minmed: [3/7] To learn more about the #safety and #efficacy of #TB #vaccine candidates in late-phase #clinicaltrials, this systematic…

[3/7] To learn more about the #safety and #efficacy of #TB #vaccine candidates in late-phase #clinicaltrials, this systematic review of #RCT's published a few weeks ago in @BioMedCentral is linked below: https://t.co/2JY7BHsBo0

RT @TiffanyGooden3: Our systematic review on the #safety and #efficacy of #TB #Vaccine candidates now published in #BMCInfectiousDiseases 7…

RT @TiffanyGooden3: Our systematic review on the #safety and #efficacy of #TB #Vaccine candidates now published in #BMCInfectiousDiseases 7…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.